tiprankstipranks

New Portfolio - New Portfolio

annu

New Portfolio
Individual Investor
Ranked #143,771 out of 747,046 TipRanks' Investors
Success Rate
64%
28 out of 44
profitable transactions
Average Return
17.17%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 1.15%
6-Month Return▲ 10.77%
12-Month Return▲ 20.98%
YTD Return▲ 13.20%
Total Return▲ 44.32%

Best Trade

Opened at
Closed at-
Gain▲ 277.56%

Bio

sky is not the limit

Performance

24.01%0-24.01%
▲ 5.14%
▲ 4.57%
▲ 5.44%
Dec 2023
▼ 1.87%
▲ 1.59%
▲ 2.33%
Jan 2024
▲ 14.08%
▲ 5.22%
▲ 10.90%
Feb 2024
▲ 5.05%
▲ 3.27%
▲ 3.84%
Mar 2024
▼ 12.40%
▼ 4.03%
▼ 4.07%
Apr 2024
▲ 11.46%
▲ 5.06%
▲ 5.68%
May 2024
▼ 2.25%
▲ 3.53%
▼ 5.80%
Jun 2024
▲ 24.01%
▲ 3.79%
▲ 0.60%
Jul 2024
TipRanks AverageS&P 500Investor Portfolio
▲ 5.14%▲ 4.57%▲ 5.44%
▼ 1.87%▲ 1.59%▲ 2.33%
▲ 14.08%▲ 5.22%▲ 10.90%
▲ 5.05%▲ 3.27%▲ 3.84%
▼ 12.40%▼ 4.03%▼ 4.07%
▲ 11.46%▲ 5.06%▲ 5.68%
▼ 2.25%▲ 3.53%▼ 5.80%
▲ 24.01%▲ 3.79%▲ 0.60%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Apogee Therapeutics, Inc.
▼ 4.37%
2
Close
Jul 11, 2024
Chipotle
0%
▼ 11.75%
1
Open
Jun 28, 2024
Permian Resources
0%
▲ 3.53%
1
Open
Jun 23, 2024
Chord Energy
0%
▲ 4.54%
1
Open
Jun 23, 2024
Broadcom
0%
▼ 2.04%
1
Open
Jun 23, 2024
Super Micro Computer
0%
▼ 1.29%
1
Open
Jun 23, 2024
Nvidia
100%
▲ 133.89%
2
Buy
Jun 20, 2024
JJill
0%
▲ 19.97%
1
Open
Jun 13, 2024
Meta Materials
0%
▼ 32.10%
1
Open
Jun 03, 2024
AstraZeneca
0%
▲ 1.55%
1
Open
May 25, 2024
Volcon
0%
▼ 84.37%
1
Open
May 25, 2024
ProShares Ultra S&P 500
▲ 29.96%
2
Close
Apr 01, 2024
Schwab US Dividend Equity ETF
▲ 14.07%
2
Close
Apr 01, 2024
Bill.com Holdings
▼ 13.92%
2
Close
Apr 01, 2024
Viking Therapeutics
0%
▼ 37.31%
1
Open
Apr 01, 2024
National Health Investors
0%
▲ 25.83%
1
Open
Mar 13, 2024
Advanced Micro Devices
0%
▼ 5.34%
1
Open
Jan 23, 2024
Icici Bank
▲ 3.53%
2
Close
Jan 17, 2024
Infosys
▲ 2.33%
4
Close
Jan 12, 2024
Direxion Daily Semiconductor Bull 3x Shares
0%
▲ 125.46%
1
Open
Nov 23, 2023